The only natural reservoir of Neisseria meningitidis is the human nasophary
ngeal mucosa,Depending on age, climate, country, socioeconomic status, and
other factors, approximately 10% of the human population harbors meningococ
ci in the nose. However invasive disease is relatively rare, as it occurs o
nly when the following conditions are fulfilled: (i) contact with a virulen
t strain, (ii) colonization by that strain, (iii) penetration of the bacter
ium through the mucosa, and (iv) survival and eventually outgrowth of the m
eningococcus in the bloodstream. When the meningococcus has reached the blo
odstream and specific antibodies are absent, as is the case for young child
ren or after introduction of a new strain in a population, the ultimate out
growth depends on the efficacy of the innate immune response. Massive outgr
owth leads within 12 h to fulminant meningococcal sepsis (FMS), characteriz
ed by high intravascular concentrations of endotoxin that set free high con
centrations of proinflammatory mediators. These mediators belonging to the
complement system, the contact system, the Fibrinolytic system, and the cyt
okine system induce shock and diffuse intravascular coagulation. FMS can be
fatal within 24 h, often before signs of meningitis have developed. In spi
te of the increasing possibilities for treatment in intensive care units, t
he mortality rate of FMS is still 30%. When the outgrowth of meningococci i
n the bloodstream is impeded, seeding of bacteria in the subarachnoidal com
partment may lead to overt meningitis within 24 to 36 h. With appropriate a
ntibiotics and good clinical surveillance the mortality rate of this form o
f invasive disease is 1 to 2%. The overall mortality rate of meningococcal
disease can only be reduced when patients without meningitis, i.e., those w
ho may develop FMS, are recognized early. This means that the fundamental n
ature of the disease as a meningococcus septicemia deserves more attention.